Quantum Computing in Healthcare Market worth $1,324.2 million by 2030

 The global quantum computing in healthcare market is projected to reach USD 1.32 billion by 2030 from USD 0.19 billion in 2024, at a high CAGR of 37.9% during the forecast period. The quantum computing in healthcare market is gaining momentum, fueled by the need for faster and more advanced data analysis in areas such as drug discovery, genomics, and precision medicine.

Browse 248 market data Tables and 52 Figures spread through 293 Pages and in-depth TOC on “Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region — Global Forecast to 2030”
View detailed Table of Content here — https://www.marketsandmarkets.com/Market-Reports/quantum-computing-in-healthcare-market-41524710.html

The quantum computing in healthcare market is progressing steadily, driven by increasing investments in quantum-focused startups and the urgent need to streamline drug development processes. Quantum computing provides unique advantages in analyzing complex biological data, allowing for faster and more precise simulations of molecular interactions and potential therapies. This capability helps reduce both the time and financial costs associated with drug discovery, making it an invaluable tool for pharmaceutical research. As healthcare organizations strive to innovate in response to growing research and development demands, the emergence of accessible, cloud-based quantum platforms makes these technologies more applicable in real-world clinical and research environments. This shift positions quantum computing as a key enabler of next-generation advancements in personalized and efficient healthcare solutions.

“The drug discovery & development segment accounted for the largest share of the quantum computing in healthcare market, by application, in 2024.”

Drug discovery & development is the largest application segment for quantum computing in healthcare. This growth is driven by the pressing need to improve the efficiency and effectiveness of research and development efforts. Quantum computing enables advanced modeling of molecular structures, simulating drug interactions, and accelerating the screening of potential compounds — all processes that are typically resource-intensive for classical computing systems. These capabilities help reduce the time and cost of discovering new treatments. Furthermore, quantum tools offer detailed insights into complex biological pathways and potential therapeutic targets. As pharmaceutical and biotech organizations work to enhance R&D productivity and minimize the risk of trial failures, quantum computing plays a crucial role in advancing next-generation drug development strategies.

“The services segment is the fastest-growing segment in the quantum computing in healthcare market, by component, during the forecast period.”

The services segment is currently experiencing the fastest growth in the quantum computing market for healthcare. This growth is driven by the increasing demand for specialized expertise to support the adoption and application of quantum technologies. As healthcare institutions begin to explore the potential of quantum computing for applications such as diagnostics, genomics, and therapeutic development, there is a rising need for professional services. These services include implementation support, system integration, training, and consulting.

Such services help bridge the gap between quantum technology providers and healthcare users, ensuring smooth deployment of technology and alignment with medical research or clinical workflows. Because quantum systems often require tailored solutions and ongoing technical assistance, the services segment is becoming essential for enabling effective and scalable adoption in healthcare settings.

“North America dominated the quantum computing in healthcare market in 2024.”

In 2024, North America led the quantum computing in healthcare market. This dominance can be attributed to several factors, including a well-developed research landscape, substantial public and private funding for advanced technologies, and a robust network of startups and academic institutions focused on quantum computing. The US and Canada are at the forefront of integrating quantum computing into healthcare, particularly in areas like personalized medicine, molecular research, and genomic analysis.

Progress in this field is fueled by active collaborations between quantum technology firms, life science companies, and healthcare organizations. Additionally, supportive government policies and national initiatives aimed at promoting computational innovation are accelerating the adoption of these technologies. The region’s advanced digital infrastructure and commitment to scientific advancement position it as a key player in shaping the future of quantum-driven healthcare innovations.

Key Players

The key players functioning in the quantum computing in healthcare market include Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), IonQ (US), Quantinuum, Ltd. (US & UK), Google, Inc. (US), Atos SE (France), QC Ware (California), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), Hefei Origin Quantum Computing Technology Co., Ltd. (China), Protiviti, Inc. (US), Quandela (France), Deloitte (UK), Accenture (Ireland), Amazon Web Services (AWS) (US), Fujitsu (Japan), Qnami (Switzerland), SEEQC (US), SandboxAQ (US), Pasqal (France), Qubit Pharmaceuticals (France), Polaris Quantum Biotech (US), and QSimulate (US).

RECENT DEVELOPMENTS

  • June 2025 : IonQ, AstraZeneca, Amazon Web Services (AWS), and NVIDIA collaborated to develop and demonstrate a quantum-accelerated computational chemistry workflow which has the potential to power world-changing innovation in healthcare, life sciences, chemistry, and more.
  • June 2025 : IonQ acquired Oxford Ionics in a transaction valued at USD 1.075 Billion, which will consist of USD 1.065 Billion in shares of IonQ common stock and approximately USD 10 Million in cash
  • June 2024 : IBM, Cleveland Clinic and Hartree Centre collaborated to advance healthcare and biomedical science through advanced computing technologies.

Download PDF Brochure


Comments

Post a Comment

Popular posts from this blog

Adhesion Barrier Industry worth $0.9 billion by 2028, with a CAGR of 7.4%

  The report   " Adhesion Barrier Market  by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region- Global Forecast to 2028" , is valued at an estimated USD 0.7 billion in 2023 and is projected to reach USD 0.9 billion by 2028, at a CAGR of 7.4% during the forecast period. The main drivers of this market's expansion are the rising number of surgeries and sports-related injuries, an increasing elderly population, and a growing understanding by of the adhesion formation and health issues linked to adhesions. On the other hand, during the forecast period, it is projected that surgeons' resistance to using adhesion barriers will impede market expansion. Browse 207 market data Tables and 50 Figures spread through 238 Pages and in-depth TOC on  "Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (F...
Read more

Exploring the Versatile Uses of Liquid Biopsies in Modern Medicine

Image
 In recent years, liquid biopsy has emerged as a groundbreaking tool in the field of medicine, offering a less invasive alternative to traditional tissue biopsies. This innovative technique, which involves the analysis of biomarkers in bodily fluids such as blood, urine, or saliva, is revolutionizing the way we diagnose, monitor, and treat various diseases. Let’s delve into the versatile uses of liquid biopsies and how they are transforming healthcare. Download PDF Brochure 1. Cancer Detection and Diagnosis One of the most significant uses of liquid biopsy is in the early detection and diagnosis of cancer. Traditional tissue biopsies can be invasive, painful, and sometimes risky. In contrast, liquid biopsies offer a non-invasive way to detect cancerous cells or DNA fragments (circulating tumor DNA or ctDNA) in the bloodstream. This allows for the identification of cancer at an earlier stage, often before symptoms appear, which can lead to more effective treatment options and i...
Read more

Exploring the Impact of Animal Genetics Testing: Revolutionizing Animal Breeding and Health

Image
 In recent years, animal genetics testing has emerged as a game-changer in the field of veterinary science and animal breeding. By unlocking the genetic makeup of animals, this innovative technology allows for a deeper understanding of their traits, health, and lineage. The implications of these insights are profound, offering significant benefits for breeders, farmers, veterinarians, and pet owners alike. Download PDF Brochure Understanding Animal Genetics Testing Animal genetics testing involves analyzing an animal's DNA to identify specific genetic markers associated with various traits and conditions. These tests can be used to determine parentage, predict the likelihood of certain diseases, and even select for desirable traits in breeding programs. The technology behind these tests has advanced rapidly, making them more accessible and affordable than ever before. Applications in Breeding One of the most significant applications of animal genetics testing is in selecti...
Read more